141 related articles for article (PubMed ID: 36708065)
1. Genome-wide Association Study of Methotrexate-Induced Liver Injury in Rheumatoid Arthritis Patients.
Eektimmerman F; Swen JJ; den Broeder AA; Hazes JMW; Kurreeman FS; Verstappen SMM; Nair N; Pawlik A; Nurmohamed MT; Dolžan V; Böhringer S; Allaart CF; Guchelaar HJ
Clin Pharmacol Ther; 2023 Apr; 113(4):916-923. PubMed ID: 36708065
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate.
Cavalli M; Eriksson N; Sundbaum JK; Wallenberg M; Kohnke H; Baecklund E; Hallberg P; Wadelius M
Pharmacogenomics; 2022 Oct; 23(15):813-820. PubMed ID: 36070248
[No Abstract] [Full Text] [Related]
3. Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate.
Sundbaum JK; Baecklund E; Eriksson N; Kohnke H; Wallenberg M; Cavalli M; Wadelius C; Wadelius M; Hallberg P
Pharmacogenomics; 2021 Oct; 22(15):973-982. PubMed ID: 34521259
[No Abstract] [Full Text] [Related]
4. Genetics are not likely to offer clinically useful predictions for elevated liver enzyme levels in patients using low dose methotrexate.
Cui J; Chasman DI; Raychaudhuri S; Xu C; Ridker PM; Solomon DH; Karlson EW
Semin Arthritis Rheum; 2022 Aug; 55():152036. PubMed ID: 35671649
[TBL] [Abstract][Full Text] [Related]
5. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
[TBL] [Abstract][Full Text] [Related]
6. Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
Choi SR; Park JW; Lee EB; Park JK
Clin Rheumatol; 2021 Nov; 40(11):4493-4500. PubMed ID: 34115231
[TBL] [Abstract][Full Text] [Related]
7. Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.
Dávila-Fajardo CL; Swen JJ; Cabeza Barrera J; Guchelaar HJ
Pharmacogenomics; 2013 Jan; 14(1):63-73. PubMed ID: 23252949
[TBL] [Abstract][Full Text] [Related]
8. Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.
Hughes LB; Beasley TM; Patel H; Tiwari HK; Morgan SL; Baggott JE; Saag KG; McNicholl J; Moreland LW; Alarcón GS; Bridges SL
Ann Rheum Dis; 2006 Sep; 65(9):1213-8. PubMed ID: 16439441
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
[TBL] [Abstract][Full Text] [Related]
10. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
11. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
[TBL] [Abstract][Full Text] [Related]
12. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.
Kooloos WM; Wessels JA; van der Straaten T; Allaart CF; Huizinga TW; Guchelaar HJ
Pharmacogenomics; 2010 Feb; 11(2):163-75. PubMed ID: 20136356
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.
Plaza-Plaza JC; Aguilera M; Cañadas-Garre M; Chemello C; González-Utrilla A; Faus Dader MJ; Calleja MA
OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation.
Senapati S; Singh S; Das M; Kumar A; Gupta R; Kumar U; Jain S; Juyal RC; Thelma BK
Pharmacogenet Genomics; 2014 Apr; 24(4):211-9. PubMed ID: 24583629
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
17. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
[TBL] [Abstract][Full Text] [Related]
18. Influence of MTHFR C677T polymorphism on methotrexate monotherapy discontinuation in rheumatoid arthritis patients: results from the GAPAID European project.
Uribarri M; Ruiz-Larrañaga O; Arteta D; Hernández L; Alcaro MC; Martínez A; Escorza-Treviño S; Estonba A; Migliorini P; Czirják L; del Amo J
Clin Exp Rheumatol; 2015; 33(5):699-705. PubMed ID: 26314492
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
[TBL] [Abstract][Full Text] [Related]
20. Association of
Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
J Int Med Res; 2020 Feb; 48(2):300060519879588. PubMed ID: 31617429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
